Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

WhatsApp-assisted telemedicine for ureteral stone management: a pilot study.

Created on 28 Sep 2026

Authors

Rifat Burak Ergul, Salvatore Butticè, M Firat Ozervarli, Ilker Teke, Emanuele Caldarera, Alberto Perez-Lanzac, Tarik Emre Sener, Laurian Dragos, Tzevat Tefik

Published in

Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica. Volume 98. Issue 3. Pages 15821. Sep 25, 2026. Epub Sep 25, 2026.

Abstract

Telemedicine has gained increasing importance in urology, particularly during the COVID-19 pandemic, enabling remote patient monitoring and reducing hospital visits. To evaluate the feasibility, safety, and effectiveness of a WhatsApp-based telemedicine follow-up model in patients with ureteral stones managed conservatively.
A cross-sectional study was conducted between March and May 2020. Ninety-nine patients with a single ureteral stone < 10 mm were included. All patients received medical expulsive therapy and were followed for 30 days using a structured WhatsApp-based monitoring system. Pain scores, analgesic use, stone passage, complications, and patient satisfaction were recorded.
The median age was 55 years, and the mean stone size was 6.1 ± 1.5 mm. Spontaneous stone passage occurred in 34.3% of patients, while 26.2% required JJ stent placement. Larger stone size (p < 0.001) and proximal location (p = 0.002) were associated with intervention. Pain scores and analgesic requirements decreased significantly over time (p < 0.01). No major complications were observed. WhatsApp-based monitoring enabled timely clinical decision-making and reduced unnecessary hospital visits.
WhatsApp-assisted telemedicine is a feasible, safe, and cost-effective approach for managing ureteral stones. Larger prospective studies are required to validate these findings.

PMID:
42803670
Bibliographic data and abstract were imported from PubMed on 28 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement